INSIDER
Relief in South Africa after J&J reversal allows key tuberculosis drug production at lower prices
Read full article: Relief in South Africa after J&J reversal allows key tuberculosis drug production at lower pricesMedical advocacy groups have welcomed Johnson & Johnson’s decision not to enforce its patent on a critical tuberculosis medication, allowing its production at much lower prices.
J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits
Read full article: J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuitsA subsidiary of Johnson & Johnson is now proposing paying approximately $6.48 billion over 25 years as part of a settlement in the U.S. to cover allegations that its baby powder containing talc caused ovarian cancer.
J&J to pump another $13B into its MedTech business with Shockwave deal
Read full article: J&J to pump another $13B into its MedTech business with Shockwave dealJohnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.
Washington state reaches a nearly $150 million settlement with Johnson & Johnson over opioid crisis
Read full article: Washington state reaches a nearly $150 million settlement with Johnson & Johnson over opioid crisisThe Washington state attorney general has announced a $149.5 million settlement agreement with drugmaker Johnson & Johnson, more than four years after the state sued the company over its role in the opioid addiction crisis.
Big Pharma's Johnson & Johnson under investigation in South Africa over 'excessive' drug prices
Read full article: Big Pharma's Johnson & Johnson under investigation in South Africa over 'excessive' drug pricesU.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging “excessive” prices for a key tuberculosis drug.
Popular nasal decongestant doesn’t actually relieve congestion, FDA experts say
Read full article: Popular nasal decongestant doesn’t actually relieve congestion, FDA experts sayGovernment advisers say the leading decongestant used by millions of Americans to treat nasal congestion doesn't actually work.
Stock market today: Asian shares are mixed as investors weigh weakness in the tech sector
Read full article: Stock market today: Asian shares are mixed as investors weigh weakness in the tech sectorShares are mixed in Asia after the rally on Wall Street fizzled with big declines for Tesla, Netflix and other big tech-oriented stocks.
J&J sales in US rise 10%, health care giant raises dividend
Read full article: J&J sales in US rise 10%, health care giant raises dividendJohnson & Johnson beat first-quarter expectations, as growth in cancer treatments and the health care giant’s home market helped counter another revenue hit from the strong dollar.
J&J subsidiary to pay $9.75M to resolve kickback allegations
Read full article: J&J subsidiary to pay $9.75M to resolve kickback allegationsFederal prosecutors say a subsidiary of health care company Johnson & Johnson has agreed to pay nearly $10 million to settle allegations that it violated federal and state law by providing free products to a surgeon.
J&J sales grow, but strong dollar tugs at expectations
Read full article: J&J sales grow, but strong dollar tugs at expectationsJohnson & Johnson topped third-quarter expectations thanks to growth in pharmaceutical sales, but the health care giant continued to tread cautiously with its outlook due to foreign exchange rates.
J&J to end sales of baby powder with talc globally next year
Read full article: J&J to end sales of baby powder with talc globally next yearJohnson & Johnson is pulling baby powder containing talc worldwide next year after it did the same in the U.S. and Canada amid thousands of lawsuits claiming it had caused cancer.
Strong Q2 at J&J, but outlook cut again due to dollar's rise
Read full article: Strong Q2 at J&J, but outlook cut again due to dollar's riseJohnson & Johnson rode growing sales of the cancer treatment Darzalex and other key drugs to a better-than-expected second quarter, but foreign exchange rates again cut into the health care giant’s 2022 forecast.
J&J's Janssen settles with WVa for $99M in opioid lawsuit
Read full article: J&J's Janssen settles with WVa for $99M in opioid lawsuitWest Virginia will receive $99 million in a settlement finalized with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. The state filed a lawsuit accusing the drugmaker of contributing to the opioid crisis in the state that's led the nation in overdose deaths.
Johnson & Johnson ordered to pay $302M in pelvic mesh case
Read full article: Johnson & Johnson ordered to pay $302M in pelvic mesh caseA California appeals court has upheld a lower court ruling that Johnson & Johnson must pay $302 million in penalties to the state for deceptively marketing pelvic mesh implants for women.
EXPLAINER: Where do US opioid trials, settlements stand?
Read full article: EXPLAINER: Where do US opioid trials, settlements stand?A trial on whether pharmacy chain Walgreens bears responsibility for the opioid crisis started Monday in Florida on the heels of opening statements last week in another opioid trial in West Virginia.
Native American tribes reach $590M settlement with Johnson & Johnson, 3 other companies over opioids
Read full article: Native American tribes reach $590M settlement with Johnson & Johnson, 3 other companies over opioidsNative American tribes have reached opioid settlements worth over a half-billion dollars with drugmaker Johnson & Johnson and three distributors.
Prescription drugs, medical devices boost J&J in Q4
Read full article: Prescription drugs, medical devices boost J&J in Q4Growing prescription drug and medical device sales nudged Johnson & Johnson past fourth-quarter earnings expectations, and the health care giant’s COVID-19 vaccine gained momentum as well.
Oregon, among last holdout states, to join opioid agreement
Read full article: Oregon, among last holdout states, to join opioid agreementOregon is on the verge of signing onto a $26 billion settlement with the three largest distributors of opioids and drugmaker Johnson & Johnson after being one of the latest holdout states to join.
EU regulators: J&J vaccine booster OK to give after 2 months
Read full article: EU regulators: J&J vaccine booster OK to give after 2 monthsThe European Union drugs regulator says people 18 and older can receive a booster shot for the Johnson & Johnson COVID-19 vaccine at least two months after their initial shot of the one-dose vaccine.
Memorial Hermann now offering COVID-19 boosters to all eligible adults 18 and over
Read full article: Memorial Hermann now offering COVID-19 boosters to all eligible adults 18 and overMemorial Hermann announced Monday that it’s now offering Pfizer and Moderna vaccine booster shots to all adults ages 18 years and older who received their second dose at least six months ago.
Oklahoma court overturns $465M opioid ruling against J&J
Read full article: Oklahoma court overturns $465M opioid ruling against J&JThe Oklahoma Supreme Court has overturned a $465 million opioid ruling against drugmaker Johnson & Johnson, finding that a lower court wrongly interpreted the state’s public nuisance law.
NBA to players, coaches, refs: Booster shots are recommended
Read full article: NBA to players, coaches, refs: Booster shots are recommendedThe NBA has told its players, coaches and referees that they should receive booster shots against the coronavirus, with particular urgency for those who received the single-dose Johnson & Johnson vaccine.
Wondering who can get a COVID-19 vaccine booster shot and when? Here’s what Texans need to know.
Read full article: Wondering who can get a COVID-19 vaccine booster shot and when? Here’s what Texans need to know.The vaccine’s protection goes down with time, so medical experts recommend a supplemental dose after two to six months. Find out here if it’s time to get one.
Watch live: Texas Attorney General Ken Paxton announces $290M statewide opioid settlement agreement with Johnson & Johnson
Read full article: Watch live: Texas Attorney General Ken Paxton announces $290M statewide opioid settlement agreement with Johnson & JohnsonTexas Attorney General Paxton will discuss an opioid settlement on Tuesday at Houston Recovery Center.
J&J hikes 2021 profit forecast, COVID-19 vaccine sales grow
Read full article: J&J hikes 2021 profit forecast, COVID-19 vaccine sales growSales of the cancer treatment Darzalex helped Johnson & Johnson deliver better-than-expected third quarter earnings, while COVID-19 fueled vaccine revenue and had more customers reaching for Tylenol.
Cities, police unions clash as vaccine mandates take effect
Read full article: Cities, police unions clash as vaccine mandates take effectPolice departments that are requiring officers to be vaccinated against COVID-19 are running up against pockets of resistance across the U.S. Police unions and officers are pushing back by filing lawsuits to block the mandates.
J&J seeks US clearance for COVID-19 vaccine booster doses
Read full article: J&J seeks US clearance for COVID-19 vaccine booster dosesJohnson & Johnson has asked U.S. regulators to allow booster shots of its COVID-19 vaccine as the U.S. government moves toward shoring up protection in more vaccinated Americans.
Slovenia police use water cannons at anti-COVID pass protest
Read full article: Slovenia police use water cannons at anti-COVID pass protestPolice in Slovenia have fired tear gas and water cannons at thousands of protesters who are against tough anti-coronavirus measures in the small European Union nation.
How much Texas gets from multistate, $26 billion opioid settlement hinges on how many local governments sign on
Read full article: How much Texas gets from multistate, $26 billion opioid settlement hinges on how many local governments sign onThe state and its political subdivisions could get up to $1.5 billion from the settlement. But some local governments are considering pursuing their own lawsuits against drug makers and distributors.
Vaccines made in South Africa to stay in Africa, says envoy
Read full article: Vaccines made in South Africa to stay in Africa, says envoyVaccine doses produced by a plant in South Africa will no longer be exported to Europe after the intervention of South Africa’s government, the African Union’s COVID-19 vaccine envoy said Thursday.
South Africa gets more vaccines from US amid ongoing surge
Read full article: South Africa gets more vaccines from US amid ongoing surgeSouth Africa will this weekend receive 2.2 million Pfizer-BioNTech vaccine doses donated by the United States to add to the 5.6 million doses it received from the U.S. in July.
Q&A: Harris County doctor explains COVID-19 booster shots
Read full article: Q&A: Harris County doctor explains COVID-19 booster shotsKPRC 2 reporter Haley Hernandez speaks with Dr. Gary Sheppard, president of the Harris County Medical Society, to break down what people need to know about the COVID-19 booster shots.
What does full approval of Pfizer’s COVID-19 vaccine mean?
Read full article: What does full approval of Pfizer’s COVID-19 vaccine mean?Pfizer’s COVID-19 vaccine has been given the Food and Drug Administration's full approval, meaning it has now undergone the same rigorous regulatory review as dozens of other established vaccines.
South African activists slam J&J for exporting vaccines
Read full article: South African activists slam J&J for exporting vaccinesHealth activists in Africa have slammed Johnson & Johnson for exporting vaccines produced in South Africa to countries in Europe, which have already immunized a large proportion of their populations and often have a surplus of vaccines.
Emergent: FDA letting troubled COVID vaccine factory restart
Read full article: Emergent: FDA letting troubled COVID vaccine factory restartThe U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine.
South Africa's vaccination drive regains pace after unrest
Read full article: South Africa's vaccination drive regains pace after unrestSouth Africa’s acting health minister says the country's COVID-19 vaccination campaign is regaining momentum after being disrupted by a week of riots sparked by the imprisonment of former President Jacob Zuma.
CDC advisers meet to discuss need for COVID-19 boosters and J&J vaccine safety
Read full article: CDC advisers meet to discuss need for COVID-19 boosters and J&J vaccine safetyVaccine advisers for the U.S. Centers for Disease Control and Prevention met Thursday to discuss recommendations on new safety issues concerning the Johnson & Johnson vaccine and to review preliminary data on whether vaccine boosters will be needed in the future, especially for people with weak immune systems.
Strong Q2 from J&J as pandemic-hit sales, profit recover
Read full article: Strong Q2 from J&J as pandemic-hit sales, profit recoverJohnson & Johnson’s second-quarter profit soared 73%, thanks to strong sales growth, particularly in its medical device and diagnostics segment, as hospitals and the health care industry as a whole continue recovering from the coronavirus pandemic.
EXPLAINER: $26B opioid settlement big step, but not the end
Read full article: EXPLAINER: $26B opioid settlement big step, but not the endA $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant — but it is far from tying a neat bow on the tangle of still-unresolved lawsuits surrounding the epidemic.
US opioid lawsuits on verge of settlements with 4 companies
Read full article: US opioid lawsuits on verge of settlements with 4 companiesThe three biggest U.S. drug distribution companies and the drugmaker Johnson & Johnson are on the verge of a $26 billion deal to settle lawsuits brought by state and local governments across the country over the toll of prescription opioids, lawyers suing on behalf of local governments said.
US to send first vaccine doses to Africa in coming days
Read full article: US to send first vaccine doses to Africa in coming daysThe U.S. will begin making its first COVID-19 vaccine shipments to Africa in the coming days, with the ultimate goal of sharing 25 million doses this summer across the continent in partnership with the African Union.
Johnson & Johnson recalling sunscreens due to benzene traces
Read full article: Johnson & Johnson recalling sunscreens due to benzene tracesJohnson & Johnson says it is recalling five of its sunscreen products after some samples were found to contained low levels of benzene, a chemical that can cause cancer with repeated exposure.
FDA to announce new warning on J&J Covid vaccine related to a rare autoimmune disorder, report says
Read full article: FDA to announce new warning on J&J Covid vaccine related to a rare autoimmune disorder, report saysU.S. regulators added a new warning to Johnson & Johnson’s COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction.
Portugal limits UK travel, stops classes amid virus surge
Read full article: Portugal limits UK travel, stops classes amid virus surgePortugal’s battle to contain the surging COVID-19 delta variant has led it to put the United Kingdom on its red list for travel and cancel school classes in the southern Algarve region, its main tourist attraction.
Johnson & Johnson asks high court to void $2B talc verdict
Read full article: Johnson & Johnson asks high court to void $2B talc verdictJohnson & Johnson is asking for Supreme Court review of a $2 billion verdict in favor of women who claim they developed ovarian cancer from using the company’s talc products.
Most in US who remain unvaccinated need convincing, poll suggests
Read full article: Most in US who remain unvaccinated need convincing, poll suggestsFewer Americans are reluctant to get a COVID-19 vaccine than just a few months ago, but questions about side effects and how the shots were tested still hold some people back.
Denmark removes J&J from vaccination program over clot fears
Read full article: Denmark removes J&J from vaccination program over clot fearsDenmark's health authorities say they have removed the single-dose Johnson & Johnson COVID-19 shot from its vaccination program to investigate reports of rare but potentially dangerous blood clots.
The Latest: Washington state resumes J&J inoculations
Read full article: The Latest: Washington state resumes J&J inoculationsGov. Jay Inslee said Saturday that inoculations with the Johnson & Johnson vaccine can begin in Washington state following a review by scientific experts in a western states work group.